Myriad Genetics Inc financial data

Symbol
MYGN on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
322 North 2200 West, Salt Lake City, UT
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 176 % -6.24%
Quick Ratio 14.8 % +11.3%
Debt-to-equity 51.4 % +24.2%
Return On Equity -12.1 % -313%
Return On Assets -13.8 % +33.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 90.8M shares +10.9%
Common Stock, Shares, Outstanding 90.9M shares +11%
Entity Public Float 1.9B USD +29.5%
Common Stock, Value, Issued 900K USD +12.5%
Weighted Average Number of Shares Outstanding, Basic 90.6M shares +10.9%
Weighted Average Number of Shares Outstanding, Diluted 90.6M shares +10.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 802M USD +14.8%
Research and Development Expense 97M USD +10.7%
Costs and Expenses 958M USD -0.41%
Operating Income (Loss) -156M USD +40.7%
Nonoperating Income (Expense) -700K USD +63.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -157M USD +40.9%
Income Tax Expense (Benefit) -1.4M USD +91.7%
Net Income (Loss) Attributable to Parent -155M USD +37.5%
Earnings Per Share, Basic -1.79 USD/shares +41.1%
Earnings Per Share, Diluted -1.79 USD/shares +41.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 92.4M USD -10.1%
Marketable Securities, Current 4.9M USD -73.9%
Cash, Cash Equivalents, and Short-term Investments 141M USD -17%
Accounts Receivable, after Allowance for Credit Loss, Current 118M USD +5.46%
Inventory, Net 26.1M USD +16%
Assets, Current 292M USD -0.92%
Property, Plant and Equipment, Net 116M USD +3.84%
Operating Lease, Right-of-Use Asset 56.5M USD -47%
Intangible Assets, Net (Excluding Goodwill) 320M USD -11%
Goodwill 286M USD -0.31%
Other Assets, Noncurrent 14.9M USD -32.6%
Assets 1.09B USD -8.6%
Accounts Payable, Current 33.3M USD -16.3%
Employee-related Liabilities, Current 45.2M USD +22.2%
Accrued Liabilities, Current 98.3M USD -40.2%
Contract with Customer, Liability, Current 500K USD -16.7%
Liabilities, Current 149M USD -32.7%
Deferred Income Tax Liabilities, Net 2.7M USD -74.3%
Operating Lease, Liability, Noncurrent 91.2M USD -38.5%
Other Liabilities, Noncurrent 34.6M USD +204%
Liabilities 345M USD -23.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4M USD +25.9%
Retained Earnings (Accumulated Deficit) -692M USD -28.9%
Stockholders' Equity Attributable to Parent 741M USD +0.72%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 886M USD -8.47%
Liabilities and Equity 1.09B USD -8.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.6M USD +44%
Net Cash Provided by (Used in) Financing Activities -8.8M USD -79.6%
Net Cash Provided by (Used in) Investing Activities -7.1M USD -121%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 90.9M shares +11%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -35.3M USD -970%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 101M USD -10.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 200K USD
Deferred Tax Assets, Valuation Allowance 95M USD +124%
Deferred Tax Assets, Gross 195M USD +21.2%
Depreciation 17.2M USD -1.15%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -155M USD +36.5%
Lessee, Operating Lease, Liability, to be Paid 161M USD -13.2%
Property, Plant and Equipment, Gross 231M USD +1.98%
Operating Lease, Liability, Current 13.3M USD -21.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 17.9M USD -24.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.5M USD +11.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 47.6M USD +152%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.6M USD -35.2%
Deferred Tax Assets, Operating Loss Carryforwards 77.1M USD +15.8%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 48.1M USD +9.57%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.7M USD -28.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 42.9M USD +2.14%
Deferred Tax Assets, Net of Valuation Allowance 100M USD -15.6%
Share-based Payment Arrangement, Expense 9.4M USD -6%
Interest Expense 2.9M USD +3.57%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%